Renat Sukhov United States

The Department of Orthopaedic Surgery is responsible for providing the full range of adult orthopaedic services to patients at the Hospital for Joint Diseases at NYU Langone Medical Center.

This specialty hospital is dedicated solely to the treatment of orthopaedic and rheumatologic conditions. Members of the Hospital for Joint Diseases service follow the highest professional standards in evaluating and treating in-hospital patients, patients who seek treatment in the numerous clinics, and patients who visit the Hospital's Immediate Care Center, a unique facility that provides urgent orthopaedic care.

NYU Langone Medical Center- Hospital for Joint Diseases
Pediatric Rehabilitation Associate Professor MD 

Mr Anthony Sun United States

Essex Group Int.

Professor Bon Sy United States

Welcome to the Department of Computer Science at Queens College of The City University of New York.   Computer Science is an exciting and rapidly changing discipline, and students at Queens College have the opportunity to study towards B.A., B.S., M.A., and Ph.D. degrees at the cutting edge of this expanding field. 

The CS Faculty at QC is composed of leading researchers in many areas of computer science, including: analysis of algorithms, complexity theory, computational linguistics, database systems, datamining, human-computer interaction, networking, operating systems, programming languages, real-time computing, security, speech technology, and visualization.

Queens College of The City University of New York | Department of Computer Science
LinkedIn logo Professor 

Miss Karen Tan United States

NYU Langone Medical Center
NP 

Dr Mark Tang United States

Corporate Overview

GCA Therapeutics Ltd (GCAT) is a US based, specialty pharmaceutical company focusing on in-licensing, acquisition and marketing of mid through late stage drug candidates and technologies from North America and the EU. GCAT applies its expertise and resources in pre-clinical, clinical, and final regulatory review and approval phases to commercialize products for use in the Chinese market. GCAT is currently in discussion with several US and European biotech and pharma firms to bring several important drugs to market through its joint venture in Tianjin, China. Initially, GCAT will market its products through a 3rd party distribution/sales partnership and will construct or acquire manufacture capabilities in China at a later date. GCAT currently has operations in New Jersey, New York, Shanghai, and Beijing.

GCA Therapeutics
Director 

Seth Taylor United States

ass Innovation Labs embodies an ecosystem of innovators in its 124,000 square foot first-class chemistry and biology space in the heart of Kendall Square. We provide comprehensive solutions for growing companies, including animal facilities, co-located CRO services and operational needs. Our goal is to reduce the time for teams to overcome hurdles on their way to a milestone. Our space offers a collaborative ecosystem that allows a company to run as a lean organization and focus on the science with expert drug development partners down the hall. 

At Milabs, our full service offerings allow you to innovate like a start up while commercializing like a pharma. 

Call us to schedule a visit!

Specialties

R&D ACCELERATION IN A COLLABORATIVE ECOSYSTEM, TOP QUALITY RESEARCH SPACES AND RESOURCES, FACILITATE BIOTECH OPPORTUNITIES, IN-HOUSE MANAGEMENT SERVICES AND EXPERTISE

Mass Innovation Labs
CFO 

Keisha Thomas United States

Keystone for Incubating Innovation in Life sciences Network, KiiLN, is an accelerator dedicated to helping early-stage biotech companies. The primary purpose of KiiLN is to address the need for business assistance for young scientific startups. We will foster a community of like-minded entrepreneurial scientists to aid in the success of these companies by providing networking, mentoring and access to experienced entrepreneurs. The KiiLN community will contribute to the growing life science community in New York by building a culture that sustains innovation.

The long-term vision of KiiLN is to create a vibrant biomedical research industry specific cluster in Manhattan and contribute to making New York City a major biotechnology hub.

KiiLN
LinkedIn logo Program Director 

Mr Nigel Thompson United States

Parks Pharma Consulting
Partner 

Mr Nathan Tinker United States

NewYorkBIO brings together over 250 of New York’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization.  We are the leading advocate for our industry in New York State.

The New York area is the largest and richest bioscience community in the world: among other assets, the region

  • boasts over 60% of Big Pharma national or global HQs;
  • supports more than 75,000 direct biotechnology jobs and was named Genetic Engineering News’s #1 region in the US to find a biotech job;
  • graduates more life science PhDs than any other region in the US;
  • is home to over 25% of the clinical trials in the US; and
  • lays claim to the world’s largest concentration of academic medical centers.

We drive innovation and support the development and growth of New York State’s life science industry, our members, and the  community by providing a network for information exchange, shared services, and collective action.

NewYorkBIO
Executive Director 

Mr Brian Toglia United States

Tanner-Ibbotson recognizes the importance of innovation and technological advances in Public Health.  Companies that research and manufacture medical devices, diagnostics, therapeutics and pharmaceuticals are exposed to risk at each level of development. An unexpected event can prevent the next big advancement from ever making it to the marketplace.  Life Science companies require a specialized comprehensive insurance and risk management program.  
 
New York State is recognized as one of the epicenters of Innovation in Life Sciences in the United States.  Tanner-Ibbotson has partnered with PRS Brokers to meet the unique and specific needs of Life Science Companies.  The partnership brings together close to 20 years experience in providing insurance and risk management solutions to the Life Science sector.
 
Expert knowledge of this industry enables us to tailor a program that can include:

  • Property
  • General Liability
  • Auto Liability
  • Product Liability
  • Professional Liability
  • Clinical Trials- US and Worldwide
  • Management Liability
  • Workers Compensation
  • Product Recall
  • Intellectual Property
  • Transit/Ocean Marine

We serve Life Science companies in all stages from Research & Development to clinical trials to commercialization.
The industry includes the following:

  • Medical Device Manufacturers & Distributors
  • Pharmaceutical Manufacturers & Distributors
  • Nutraceuticals/Supplements Manufacturers & Distributors
  • Biotechnology Companies
  • Medical Software Developers
  • Nanotechnology Companies
  • Contract Drug or Device Manufacturers
  • Contract Research Organizations
  • Site Management Organizations
Tanner-Ibbotson, Inc.
Vice President